These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 34468866)

  • 21. New chromatographic insights on drug:cyclodextrin inclusion complexes and their potential use in drug delivery.
    Constantin M; Cosman B; Ascenzi P; Simionescu BC; Fundueanu G
    Expert Opin Drug Deliv; 2022 Dec; 19(12):1696-1709. PubMed ID: 36372064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymol/cyclodextrin inclusion complex nanofibrous webs: Enhanced water solubility, high thermal stability and antioxidant property of thymol.
    Celebioglu A; Yildiz ZI; Uyar T
    Food Res Int; 2018 Apr; 106():280-290. PubMed ID: 29579928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Core-shell nanofibers of curcumin/cyclodextrin inclusion complex and polylactic acid: Enhanced water solubility and slow release of curcumin.
    Aytac Z; Uyar T
    Int J Pharm; 2017 Feb; 518(1-2):177-184. PubMed ID: 28057465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
    Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
    AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hydroxypropyl-beta-cyclodextrin and pH on the solubility of levemopamil HCl.
    McCandless R; Yalkowsky SH
    J Pharm Sci; 1998 Dec; 87(12):1639-42. PubMed ID: 10189280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced antibacterial activity of levofloxacin/hydroxypropyl-β-cyclodextrin inclusion complex: In vitro and in vivo evaluation.
    Li Y; Zhou J; Gu J; Shao Q; Chen Y
    Colloids Surf B Biointerfaces; 2022 Jul; 215():112514. PubMed ID: 35490541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T; Dressman JB; Buchanan CM; Klein S
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sertaconazole/hydroxypropyl-beta-cyclodextrin complexation: isothermal titration calorimetry and solubility approaches.
    Rodriguez-Perez AI; Rodriguez-Tenreiro C; Alvarez-Lorenzo C; Taboada P; Concheiro A; Torres-Labandeira JJ
    J Pharm Sci; 2006 Aug; 95(8):1751-62. PubMed ID: 16795015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of piroxicam: hydroxypropyl-beta-cyclodextrin complexation on the in vitro permeation and skin retention of piroxicam.
    Doliwa A; Santoyo S; Ygartua P
    Skin Pharmacol Appl Skin Physiol; 2001; 14(2):97-107. PubMed ID: 11316968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
    Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
    Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
    Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
    Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal inclusion complexes between barbiturates and 2-hydroxypropyl-beta-cyclodextrin in aqueous solution: isothermal titration microcalorimetry, (13)C NMR spectrometry, and molecular dynamics simulation.
    Aki H; Niiya T; Iwase Y; Yamamoto M
    J Pharm Sci; 2001 Aug; 90(8):1186-97. PubMed ID: 11536223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Removing Control of Cyclodextrin-Drug Complexes Using High Affinity Molecule.
    Kim YH; Kim ST; Jee JP; Kim DY; Kang D; Kim K; Park SY; Sim T; Cho KH; Jang DJ
    J Nanosci Nanotechnol; 2018 Feb; 18(2):898-901. PubMed ID: 29448513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physico-chemical characterization and in vitro dissolution assessment of clonazepam-cyclodextrins inclusion compounds.
    Patel R; Purohit N
    AAPS PharmSciTech; 2009; 10(4):1301-12. PubMed ID: 19885735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability enhancement of poorly water soluble and weakly acidic new chemical entity with 2-hydroxy propyl-beta-cyclodextrin: selection of meglumine, a polyhydroxy base, as a novel ternary component.
    Basavaraj S; Sihorkar V; Shantha Kumar TR; Sundaramurthi P; Srinivas NR; Venkatesh P; Ramesh M; Kumar Singh S
    Pharm Dev Technol; 2006; 11(4):443-51. PubMed ID: 17101515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfisoxazole/cyclodextrin inclusion complex incorporated in electrospun hydroxypropyl cellulose nanofibers as drug delivery system.
    Aytac Z; Sen HS; Durgun E; Uyar T
    Colloids Surf B Biointerfaces; 2015 Apr; 128():331-338. PubMed ID: 25769282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L; Zhu S
    J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chitosan microspheres with hydrocortisone and hydrocortisone-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Filipović-Grcić J; Voinovich D; Moneghini M; Becirevic-Lacan M; Magarotto L; Jalsenjak I
    Eur J Pharm Sci; 2000 Feb; 9(4):373-9. PubMed ID: 10664477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
    Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
    J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer.
    Fine-Shamir N; Beig A; Zur M; Lindley D; Miller JM; Dahan A
    Mol Pharm; 2017 Jun; 14(6):2138-2146. PubMed ID: 28505451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.